Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Arjun Pandey(University of Ottawa), William F. McIntyre(Population Health Research Institute), Emilie P. Belley‐Côté(McMaster University), Hertzel C. Gerstein(McMaster University), Hargun Kaur(McMaster University), Jack Young(McMaster University), Jorge Wong(Population Health Research Institute), Alireza Oraii(Tehran University of Medical Sciences), Iva Okaj(McMaster University), David Conen(Yamaha (Japan)), Alexander P. Benz(Population Health Research Institute), Subodh Verma(St. Michael's Hospital), Linda Johnson(Lund University), Jia Wang(Shantou University), Jeff S. Healey(Population Health Research Institute)
Cited by 130
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k